Consider Tesla (TSLA) as a long-term investment in AI and robotics, viewing current weakness as a buying opportunity that looks beyond short-term car sales. Hims & Hers Health (HIMS) is presented as a significantly undervalued growth stock, disrupting healthcare with strong underlying business performance. For a high-growth real estate investment, The Real Brokerage Inc. (REAX) is identified as a "dirt cheap" and profitable company with a superior, low-capital business model. For investors with a high risk tolerance, Nebius (NBIS) offers hyper-growth potential of over 1,500% due to its strategic partnership with NVIDIA. These opportunities are based on long-term theses where the market is believed to be mispricing future potential.

MicroStrategy (MSTR)

• The speaker is bullish on MSTR, viewing the current shareholder base as strong, long-term believers who have weathered recent volatility, not short-term "tourists."
• A recent "Saylor ATM" (At-The-Market offering) was seen as a significant positive event that the speaker had been anticipating for over a month and a half.
• The speaker notes that the stock's short-term price movements are "nonsensical" and difficult to predict. At the time of recording, MSTR was down over 3%, dropping more than Bitcoin itself.
• They believe that most investors who bought at higher prices (e.g., $300+, $400+) have likely already sold, leaving a core group of committed shareholders.

Takeaways

• The investment thesis for MSTR is for long-term believers in the company's Bitcoin strategy, led by Michael Saylor.
• Investors should be prepared for extreme short-term volatility that may not always correlate directly with Bitcoin's price movements.
• The speaker implies that the "tourist" investors have been shaken out, potentially creating a more stable, long-term shareholder base.

Bitcoin (BTC)

• Bitcoin was mentioned as dropping in price at the time of the recording.
• The Bitcoin ETF IBIT was also noted as being down.
• Its price drop was used as a reference point to highlight that MicroStrategy (MSTR) was falling even more sharply, indicating MSTR can have higher volatility than the underlying asset it holds.

Takeaways

• The primary insight is the relationship between BTC and its main public proxy, MSTR.
• While MSTR's value is heavily tied to Bitcoin, its stock can experience amplified volatility, falling more than Bitcoin on a down day.

Tesla (TSLA)

• The speaker is extremely bullish on TSLA, considering it a core holding in their "trifecta" of top picks.
• They argue that the market is incorrectly valuing Tesla based on short-term car sales data, such as recent numbers from Germany.
• The speaker views selling cars as a "side quest" or "legacy business" for Tesla. The true investment thesis lies in the "bigger story" of the business (e.g., AI, robotics, FSD), which is not reflected in the current stock price.
• Negative news, such as competitor demos at CES or NVIDIA releasing a competing self-driving platform, is dismissed as market noise.

Takeaways

• The investment case for Tesla is based on its long-term potential as an AI and technology company, not just an automaker.
• Investors are advised to look past short-term volatility caused by car sales figures or competitor announcements.
• The speaker sees the current price drop as an opportunity for investors who believe in the company's long-term, disruptive vision.

Hims & Hers Health (HIMS)

• The speaker is very bullish on HIMS, including it in their "trifecta" of top picks alongside Tesla and MicroStrategy.
• The core thesis is that HIMS is disrupting "sick care" by creating a new category of "healthcare," a concept the speaker believes the market does not yet understand.
• The stock is described as being "as cheap as I've seen it," citing a proprietary valuation metric ("EV over GP over RG") at 0.10.
• It is highlighted for its strong fundamentals, with a "Rule of 40" score of 60, which suggests a healthy balance of growth and profitability.

Takeaways

• HIMS is presented as an undervalued growth stock with a significant, misunderstood long-term vision for the healthcare industry.
• The current price is seen as a buying opportunity, given its low valuation metrics and strong underlying business performance (high growth and efficiency).

Nebius (NBIS)

• The speaker is exceptionally bullish on Nebius, describing it as a fascinating but highly volatile stock.
• The primary catalyst is the company's massive predicted revenue growth of 1,500% to 2,000% (a 15x increase).
• A key strength is its deep partnership with NVIDIA, which includes cross-stock purchases and gives Nebius early access to NVIDIA's next-generation "Rubin" platform in 2026.
• The company's leadership is also a positive factor, with the founder of Yandex ("the Russian Google") leading the company.
• The speaker believes the market "doesn't know how to value the stock," leading to manic-depressive price swings but also making it "twice as cheap as HIMSS" on a relative basis.

Takeaways

• NBIS is positioned as a high-risk, high-reward hyper-growth investment.
• The investment thesis is built on its staggering revenue growth projections and its strategic, high-level partnership with NVIDIA.
• Investors should expect extreme volatility, as the speaker believes the market is struggling to price the company's future potential correctly.

The Real Brokerage Inc. (REAX)

• The speaker is bullish and identifies REAX as their preferred real estate investment.
• Its business model is seen as superior to competitors like Open Door (OPEN) because it is less "capital heavy." REAX focuses on attracting the top 10% of real estate agents with a compelling commission structure rather than flipping houses.
• The company has a strong track record and future outlook:
  • Predicted to grow revenue by 50% over the next 12 months.
  • Has historically grown 50% year-over-year for the past five years.
  • Is already profitable.
  • Achieves a "Rule of 40" score of 53.
• The stock is described as "dirt cheap," trading at an Enterprise Value to forward profit of 3x and a price-to-sales ratio of 0.27x. The speaker notes that low sales multiples are common in real estate due to low margins.

Takeaways

• REAX is presented as a "dirt cheap," profitable, and high-growth company in the real estate sector.
• Its agent-centric, low-capital business model is a key advantage.
• The combination of a proven growth history, profitability, and a very low valuation makes it a compelling investment opportunity, according to the speaker.